Malta - Inggeris - Medicines Authority

octapharma (ip) sprl alle de la recherche 65, 1070 (anderlecht), belgium - human von, willebrand factor, human coagulation, factor xiii - powder and solvent for solution for injection - human von willebrand factor 1000 iu human coagulation factor viii 1000 iu - antihemorrhagics

Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

octapharma limited - factor viii (antihaemophilic factor), von willebrand factor human - pdr+solv for soln for inj - 1000/1000 international unit - blood coagulation factors

Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

octapharma limited - factor viii (antihaemophilic factor), von willebrand factor human - pdr+solv for soln for inj - 500/500 international unit - blood coagulation factors

Malaysia - Inggeris - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

takeda malaysia sdn bhd - factor ix fraction,dried -

Israel - Inggeris - Ministry of Health

pfizer pharmaceuticals israel ltd - moroctocog alfa - lyophylized powder and solvent for solution for injection - moroctocog alfa 500 iu/vial - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency)

Israel - Inggeris - Ministry of Health

pfizer pharmaceuticals israel ltd - moroctocog alfa - powder and solvent for solution for injection - moroctocog alfa 1000 iu/vial - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency)

Israel - Inggeris - Ministry of Health

pfizer pharmaceuticals israel ltd - moroctocog alfa - powder and solvent for solution for injection - moroctocog alfa 2000 iu/vial - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency)

Malta - Inggeris - Medicines Authority

octapharma (ip) limited - human von willebrand factor; human coagulation factor viii - powder and solvent for solution for injection - human von willebrand factor 500 iu; human coagulation factor viii 500 iu - antihemorrhagics

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - factor ix, quantity: 50 iu/ml - injection, diluent for - excipient ingredients: water for injections - "tbsf" high purity factor ix concentrate is indicated for the treatment of haemorrhages, for use in surgery, and as prophylaxis in patients with haemophilia b. "tbsf" high purity factor ix concentrate is not indicated for the treatment of factor ii, vii or x deficiencies because it does not contain therapeutic levels of these coagulation factors. "tbsf" high purity factor ix concentrate is not indicated for the treatment of haemophilia a patients with factor viii inhibitors.

United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

1,000unit) powder and 20ml solvent for solution for infusion vials (takeda uk ltd - factor viii inhibitor bypassing fraction - powder and solvent for solution for infusion - 1000unit